• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非痴呆个体中载脂蛋白 E4 携带者的比例:38.9 万社区居住者的汇总分析。

The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.

机构信息

Department of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Dalian, China.

Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.

出版信息

J Alzheimers Dis. 2021;81(3):1331-1339. doi: 10.3233/JAD-201606.

DOI:10.3233/JAD-201606
PMID:33935087
Abstract

BACKGROUND

The apolipoprotein E epsilon 4 (APOE4) is the strongest genetic risk factor for sporadic Alzheimer's disease (AD). Its carriage percentage in non-demented population varies across geographic regions and ethnic groups.

OBJECTIVE

To estimate the proportion of APOE4 (2/4, 3/4, or 4/4) carriers in non-demented community-dwellers.

METHODS

PubMed, EMBASE, and China National Knowledge Infrastructure were searched from inception to April 20, 2020. Community-based studies that reported APOE polymorphisms with a sample of≥500 non-demented participants were included. Random-effects models were used to pool the results. Meta-regression and subgroup analyses were performed to test the source of heterogeneity and stratified effects. Age-standardized pooled proportion estimates (ASPPE) were calculated by direct standardization method.

RESULTS

A total of 121 studies were included, with a pooled sample of  389,000 community-dwellers from 38 countries. The global average proportion of APOE4 carriers was 23.9% (age-standardized proportion: 26.3%; 2.1% for APOE4/4, 20.6% for APOE3/4 and 2.3% for APOE2/4), and varied significantly with geographical regions (from 19.3% to 30.0%) and ethnic groups (from 19.1% to 37.5%). The proportion was highest in Africa, followed by Europe, North America, Oceania, and lowest in South America and Asia (p < 0.0001). With respect to ethnicity, it was highest in Africans, followed by Caucasians, and was lowest in Hispanics/Latinos and Chinese (p < 0.0001).

CONCLUSION

APOE4 carriers are common in communities, especially in Africans and Caucasians. Developing precision medicine strategies in this specific high-risk population is highly warranted in the future.

摘要

背景

载脂蛋白 E ɛ 4(APOE4)是散发性阿尔茨海默病(AD)最强的遗传风险因素。其在非痴呆人群中的携带率因地理位置和种族群体而异。

目的

估计非痴呆社区居民中 APOE4(2/4、3/4 或 4/4)携带者的比例。

方法

检索了从建库至 2020 年 4 月 20 日的 PubMed、EMBASE 和中国国家知识基础设施数据库。纳入了报告 APOE 多态性且样本量≥500 名非痴呆参与者的基于社区的研究。使用随机效应模型汇总结果。进行了荟萃回归和亚组分析,以检验异质性来源和分层效应。通过直接标准化法计算年龄标准化的汇总比例估计值(ASPPE)。

结果

共纳入 121 项研究,包含来自 38 个国家的 389000 名非痴呆社区居民的汇总样本。APOE4 携带者的全球平均比例为 23.9%(年龄标准化比例:26.3%;APOE4/4 为 2.1%,APOE3/4 为 20.6%,APOE2/4 为 2.3%),且在地理位置(19.3%至 30.0%)和种族群体(19.1%至 37.5%)之间差异显著。在非洲最高,其次是欧洲、北美、大洋洲,在南美和亚洲最低(p<0.0001)。就种族而言,在非洲最高,其次是白种人,在西班牙裔/拉丁裔和中国人中最低(p<0.0001)。

结论

APOE4 携带者在社区中很常见,尤其是在非洲人和白种人中。在未来,非常有必要针对这一特定高危人群制定精准医学策略。

相似文献

1
The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.非痴呆个体中载脂蛋白 E4 携带者的比例:38.9 万社区居住者的汇总分析。
J Alzheimers Dis. 2021;81(3):1331-1339. doi: 10.3233/JAD-201606.
2
Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.载脂蛋白 E2、E3 和 E4 通过不同信号通路在人神经元中介导阿尔茨海默病风险。
J Neurosci. 2019 Sep 11;39(37):7408-7427. doi: 10.1523/JNEUROSCI.2994-18.2019. Epub 2019 Jul 22.
3
In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.在泰国人群中,载脂蛋白 E4 等位基因影响神经心理学、生物行为和社会功能的多个领域,从而导致阿尔茨海默病,而载脂蛋白 E3 等位基因则可预防神经精神症状和社会心理缺陷。
Mol Neurobiol. 2018 Aug;55(8):6449-6462. doi: 10.1007/s12035-017-0848-0. Epub 2018 Jan 6.
4
Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.载脂蛋白 E ε4 在全球不同人群阿尔茨海默病患者中的流行率存在差异:一项系统文献回顾和荟萃分析。
Dement Geriatr Cogn Disord. 2011;31(1):20-30. doi: 10.1159/000321984. Epub 2010 Dec 1.
5
Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.APOE2和APOE4对老年人脑微观结构的影响:年龄、性别和认知状态的调节作用。
Alzheimers Res Ther. 2024 Jan 11;16(1):7. doi: 10.1186/s13195-023-01380-w.
6
Vascular Dysfunction Is Central to Alzheimer's Disease Pathogenesis in APOE e4 Carriers.血管功能障碍是载脂蛋白 E4 携带者阿尔茨海默病发病机制的核心。
Int J Mol Sci. 2022 Jun 26;23(13):7106. doi: 10.3390/ijms23137106.
7
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.无症状 APOE4 携带者的阿尔茨海默病神经影像学生物标志物。
Rev Neurol (Paris). 2013 Oct;169(10):729-36. doi: 10.1016/j.neurol.2013.07.025. Epub 2013 Sep 6.
8
APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.与血浆相比,APOE ε3/ε4杂合子脑脊液中载脂蛋白E4的比例升高,这与阿尔茨海默病的诊断无关。
Exp Neurol. 2003 Sep;183(1):249-53. doi: 10.1016/s0014-4886(03)00088-8.
9
Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.血浆 ApoE4 水平低于 ApoE2 和 ApoE3 水平,且与阿尔茨海默病淀粉样蛋白-β 淀粉样变性的生物标志物血浆 Aβ40/42 比值无关。
J Alzheimers Dis. 2023;93(1):333-348. doi: 10.3233/JAD-220996.
10
APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM Polluted Cities.载脂蛋白 E 外周和大脑影响:载脂蛋白 E4 携带者加速其阿尔茨海默病连续体,并在 PM 污染城市有高自杀风险。
Biomolecules. 2023 May 31;13(6):927. doi: 10.3390/biom13060927.

引用本文的文献

1
Clinical Significance of APOE4 Genotyping: Potential for Personalized Therapy and Early Diagnosis of Alzheimer's Disease.APOE4基因分型的临床意义:阿尔茨海默病个性化治疗与早期诊断的潜力
J Clin Med. 2025 Aug 26;14(17):6047. doi: 10.3390/jcm14176047.
2
The hypoperfusion intensity ratio associates with APOE gene polymorphism in acute ischemic stroke patients with large vessel occlusion.在伴有大血管闭塞的急性缺血性卒中患者中,低灌注强度比值与APOE基因多态性相关。
Sci Rep. 2025 Sep 2;15(1):32288. doi: 10.1038/s41598-025-16237-5.
3
Sleep quality, APOE ε4, and Alzheimer's disease: associations from two prospective cohort studies and mechanisms by plasma proteomic analysis.
睡眠质量、载脂蛋白Eε4与阿尔茨海默病:两项前瞻性队列研究的关联及血浆蛋白质组学分析机制
BMC Med. 2025 Aug 6;23(1):462. doi: 10.1186/s12916-025-04255-z.
4
Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction.一碳代谢、相关B族维生素及载脂蛋白E基因型与老年人认知功能的关联:一种新型基因-营养素相互作用的鉴定
BMC Med. 2025 Jul 28;23(1):440. doi: 10.1186/s12916-025-04276-8.
5
A novel biochemical analysis for ApoE4 quantification in plasma and discrimination of homozygous and heterozygous APOE ε4 carriers.一种用于定量血浆中载脂蛋白E4(ApoE4)以及区分纯合子和杂合子APOE ε4携带者的新型生化分析方法。
Alzheimers Res Ther. 2025 Jul 15;17(1):163. doi: 10.1186/s13195-025-01811-w.
6
Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans.创伤性脑损伤中的β淀粉样蛋白和tau蛋白沉积:对越战老兵的一项研究。
Brain Commun. 2025 Jan 10;7(1):fcaf009. doi: 10.1093/braincomms/fcaf009. eCollection 2025.
7
Systolic blood pressure variability in late-life predicts cognitive trajectory and risk of Alzheimer's disease.晚年收缩压变异性可预测认知轨迹及患阿尔茨海默病的风险。
Front Aging Neurosci. 2024 Oct 3;16:1448034. doi: 10.3389/fnagi.2024.1448034. eCollection 2024.
8
Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories.种族差异与淀粉样蛋白阳性率和认知轨迹。
Alzheimers Dement. 2024 Nov;20(11):7556-7566. doi: 10.1002/alz.14247. Epub 2024 Sep 24.
9
Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases.机器学习对 131 例脑库病例颞叶淀粉样蛋白-β沉积的定量分析。
Acta Neuropathol Commun. 2024 Aug 17;12(1):134. doi: 10.1186/s40478-024-01827-7.
10
Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer's Disease.载脂蛋白 E4 在阿尔茨海默病发病机制中的氧化脂质代谢和铁死亡中的多种作用。
J Mol Neurosci. 2024 Jul 3;74(3):62. doi: 10.1007/s12031-024-02224-4.